BD Matrigel™ Basement Membrane Matrix
Certified LDEV-Free
BD™ Human Umbilical Vein Endothelial Cells (HUVEC-2) stained with Calcein AM and cultured on BD Matrigel™ Matrix. Confocal image (4x) taken using the BD Pathway™ BioImager.
BD Matrigel Basement Membrane Matrix is a solubilized basement membrane preparation extracted from the Engelbreth-Holm-Swarm (EHS) mouse sarcoma, a tumor rich in extracellular matrix proteins to include laminin (a major component), collagen IV, heparan sulfate proteoglycans, and entactin/nidogen.1,2 BD Matrigel Matrix also contains TGF-beta, epidermal growth factor, insulin-like growth factor, fibroblast growth factor, tissue plasminogen activator,3,4 and other
growth factors which occur naturally in the EHS tumor.
™
BD Matrigel™ Basement Membrane Matrix is effective for the attachment and
differentiation of both normal and transformed anchorage dependent epithelioid and other cell types. These include neurons,5,6 Sertoli cells,7 chick lens,8 and vascular endothelial cells,9 and hepatocytes.10 BD Matrigel Matrix will influence gene expression in adult rat hepatocytes11 as well as three dimensional culture in mouse12-15 and human16,17 mammary epithelial cells. It will support in vivo peripheral nerve regeneration,18-20 can be used for metabolism and toxicology studies,21,22 and is the basis for several types of tumor cell invasion assays.23,24 BD Matrigel Matrix provides the substrate necessary for the study of angiogenesis both in vitro25,26 and in vivo.27-29 BD Matrigel Matrix also supports in vivo propagation of human tumors in immunosupressed mice.30-32
Wide Selection of Basement Membrane Matrices:
BD Matrigel Matrix Growth Factor Reduced (GFR) is suited for applications where a more highly defined basement
membrane preparation is desired. Available in standard GFR, High Concentration (HC), and Phenol Red-Free formats.
BD Matrigel Matrix High Concentration is suited for in vivo applications where a high protein concentration augments growth of tumors. The high protein
concentration also allows the BD Matrigel Matrix Plug to maintain its integrity after subcutaneous injection into mice. Available in Standard, Growth Factor Reduced (GFR), and Phenol Red-Free formats.
BD Matrigel Matrix Phenol Red-Free is recommended for assays which require color detection (i.e. fluorescence).
BD Matrigel hESC-qualified Matrix has been qualified as mTeSR™1-compatible by StemCell Technologies, thus eliminating the need for time-consuming screening, in order to provide the reproducibility and consistency essential for your human embryonic stem (hES) cell research. The mTeSR1 formulation and BD Matrigel Matrix have been shown to be a successful combination for feeder-free maintenance of different WiCell™ hES cell lines for up to 20 passages (mTeSR1, StemCell Technologies Cat. No. 05850).
BD Biosciences
bdbiosciences.com
BD Matrigel™Basement Membrane MatrixTypical Applications:
Cell Growth and Differentiation
BD Matrigel Matrix is especially suited for the culture of polarized cells, such as epithelial cells. It promotes the differentiation of many cells types,
including hepatocytes, neurons, mammary epithelial, endothelial, and smooth muscle cells.
In Vivo Angiogenesis Studies
BD Matrigel Matrix HC can be used to assess in vivo angiogenic activity of different compounds by subcutaneous injection into mice (BD Matrigel Plug Assay). The plugs are subsequently
removed and analyzed for the formation of blood vessels.
Augmentation of Tumor Growth in Nude Mice
BD Matrigel Matrix HC has been shown to promote successful transplantation of many human tumor cells, including prostatic, breast, small-cell lung, colon, adrenal carcinomas, melanomas, and lymphoblastic leukemia cells. Also, it has been found to increase tumor growth rates in vivo.
To place an order, please contact your local distributor or nearest BD Biosciences office.
For technical assistance, please contact Scientific Support at: help.biosciences@bd.com
For literature citations and other BD™ Extracellular Matrix products, please visit bdbiosciences.com.
For research use only. Not intended for use in diagnostic or therapeutic procedures.
mTeSR is a trademark of WiCell Research Institute.
BD, BD Logo, and all other trademarks are the property of Becton, Dickinson and Company. ©2008 BDXEUR4247-00
Quality Control:
•Mouse colonies are routinely screened for pathogens via Mouse Antibody Production (MAP) testing•Extensive PCR testing is performed to screen for a number of pathogens, including LDEV, to ensure strict control of raw materials used during the manufacturing process•Tested and found negative for bacteria, fungi, and mycoplasma•Protein concentrations are determined by Lowry method
•Endotoxin units are measured by Limulus Amoebocyte Lysate assay•BD Matrigel Matrix gel stability is tested for a period of 14 days at 37°C
•Biological activity is determined for each lot using a neurite outgrowth assay. Chick dorsal root ganglia are plated on a 1.0 mm layer of BD Matrigel Matrix and must generate positive neurite outgrowth response after 48 hours without addition of nerve growth factor
Ordering InformationDescription Qty. Cat. No.BD Matrigel™ Basement Membrane MatrixBD Matrigel Matrix 5 ml 356234BD Matrigel Matrix 10 ml 354234BD Matrigel Matrix 5 x 10 ml 356235BD Matrigel Matrix High Concentration 10 ml 354248BD Matrigel Matrix Phenol Red-Free 10 ml 356237BD Matrigel Matrix High Concentration, Phenol Red-Free 10 ml 354262BD Matrigel Matrix Growth Factor Reduced 5 ml 356230BD Matrigel Matrix Growth Factor Reduced 10 ml 354230BD Matrigel Matrix Growth Factor Reduced, 10 ml 354263 High Concentration
BD Matrigel Matrix Growth Factor Reduced, Phenol Red-Free 10 ml 356231BD Matrigel hESC-qualified Matrix 5 ml
354277
Typical protein concentrations for BD Matrigel Matrix are between 9-12 mg/ml. BD Matrigel Matrix High Concentration is 18-22 mg/ml. A lot-specific Certificate of Analysis is included in each BD Matrigel Matrix shipment noting exact endotoxin and protein concentrations.
BD BiosciencesEurope
- Discovery Labware
POB 13, Erembodegem-Dorp 86B-9320 ErembodegemTel.: (32) 2 400 98 95Fax: (32) 2 401 70 94
contact_bdb@europe.bd.combdbiosciences.com
AUSTRIA Tel: (3) 1 706.36.60.20
customerservice.bdb.at@europe.bd.comNORWAY Tel: (47) 73591200norge@europe.bd.com
BELGIUM Tel: (32) 53 720.550
customer_service_bdbelgium@europe.bd.comPORTUGAL Tel: (351) 21 421.93.30enzifarma@enzifarma.pt
DENMARK Tel: (45) 43 43.45.66bdcs_dk_dk@europe.bd.com
SPAIN Tel: (34) 90 227.17.27
servicio_de_clientes@europe.bd.comEASTERN EUROPE (EMA) Tel: (49) 6221.305.161bdb.ema@europe.bd.comSWEDEN Tel: (46) 8 775.51.10bdbnordic@europe.bd.com
FINLAND Tel: (358) 9 8870 7832asiakaspalvelu@europe.bd.com
SWITZERLAND Tel: (41) 61 485.22.22customerservice.bdb.ch@europe.bd.comFRANCE Tel: (33) 4 76.68.36.40
customerservice.bdb.france@europe.bd.comTHE NETHERLANDS Tel: (31) 20 582.94.20customer_service_bdholland@europe.bd.comGERMANY Tel: (49) 6221.305.551
customerservice.bdb.de@europe.bd.com
UK Tel: (44) 1865 781688
BDUK_CustomerService@europe.bd.com
GREECE Tel.: (30) 210 940.77.41ITALY Tel: (39) 02 48.240.1
ordini_diagnostico@europe.bd.com
